Video – Hyosung
Cutting-edge ATM solutions were the focus of the Hyosung Innovue kick-off event on June 20, 2023. New technology and capabilities give retailers exciting revenue-enhancing opportunities through the latest ATM innovations.
Latest
Hyosung
Hyosung’s Cajera Series brings Multifunctionality to Cash Management Devices, Creating Additional Revenue Stream Possibilities
Hyosung Innovue is revolutionizing the cash ecosystem with upgraded ATM solutions in its Cajera Series of cash management devices. These innovative ATMs bridge the gap between various cash points within retail spaces to enhance customer convenience while creating additional revenue streams for retailers. By integrating cash recycling, remittances, bill payments, cryptocurrency purchases, visa deposits,…
Hospitality
Multifunctional Cajera Series ATMs Unveiled by Hyosung Innovue: A Game-Changer in Finance
Hyosung Innovue has announced its new ATMs in the Cajera™ series, aiming to simplify the financial journey for customers. The innovative Cajera 4 and Cajara 2 ATMs offer various services such as DigitalMint, MoneyGram, Fiserv, and BillPay, with users being able to choose which services to enable on their devices, increasing transactions per customer….
Latest
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…
What’s Next in Preclinical Cancer Immunotherapy Research?
As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
